References
- Agrawal, S. (1999). Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.Biochim. Biophys. Acta 1489(1):53–68. [PUBMED], [INFOTRIEVE]
- Akhtar, S., Kole, R., Juliano, R. L. (1991). Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera.Life Sci. 49(24):1793–1801. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Allen, T. M., Cullis, P. R. (2004). Drug delivery systems: entering the mainstream.Science. 303(5665):1818–1822. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bally, M. B., Harvie, P., Wong, F. M., Kong, S., Wasan, E. K., Reimer, D. L. (1999). Biological barriers to cellular delivery of lipid-based DNA carriers.Adv. Drug Deliv. Rev. 38(3):291–315. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bartsch, M., Weeke-Klimp, A. H., Meijer, D. KF., Scherphof, G. L., Kamps, J. AAM. (2002). Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells.Pharm. Res. 19(5):676–680. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bartsch, M., Weeke-Klimp, A. H., Morselt, H. WM., Kimpfler, A., Asgeirsdottir, S. A., Schubert, R., Meijer, D. KF., Scherphof, G. L., Kamps, J. A. A. M. (2005). Optimized targeting of PEG-stabilized anti-ICAM-1 ODN/lipid particles to liver sinusoidal endothelial cells. Mol. Pharmacol. 67(3):883–890. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Belikova, A. M., Zarytova, V. F., Grineva, N. I. (1967). Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues.Tetrahedron Lett. 37:3557–3562. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E., Mirabelli, C. K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.Mol. Pharmacol. 41(6):1023–1033. [PUBMED], [INFOTRIEVE], [CSA]
- Blumenthal, R., Morris, S. J. (1999). The influenza haemagglutinin-induced fusion cascade: effects of target membrane permeability changes.Mol. Membr. Biol. 16(1):43–47. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., Behr, J. P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proc. Natl. Acad. Sci. U. S. A. 92(16):7297–7301. [CSA]
- Brignole, C., Pagnan, G., Marimpietri, D., Cosimo, E., Allen, T. M., Ponzoni, M., Pastorino, F. (2003). Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.Cancer Lett. 197(1–2):231–235. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brown, M. S., Goldstein, J. L. (1986). A receptor-mediated pathway for cholesterol homeostasis.Science. 232(4746):34–47. [PUBMED], [INFOTRIEVE]
- Brown, S. A., Jarvis, T. C. (1997). Optimization of lipid-mediated ribozyme delivery to cells in culture.Methods Mol. Biol. 74:441–449. [PUBMED], [INFOTRIEVE]
- Brown, M. D., Schatzlein, A. G., Uchegbu, I. F. (2001). Gene delivery with synthetic (non viral) carriers.Int. J. Pharm. 229(1–2):1–21. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brunner, S., Sauer, T., Carotta, S., Cotten, M., Saltik, M., Wagner, E. (2000). Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus.Gene Ther. 7(5):401–407. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brunner, S., Furtbauer, E., Sauer, T., Kursa, M., Wagner, E. (2002). Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation.Mol. Ther. 5(1):80–86. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brzezinska, A., Winska, P., Balinska, M. (2000). Cellular aspects of folate and antifolate membrane transport.Acta Biochim. Pol. 47(3):735–749. [PUBMED], [INFOTRIEVE], [CSA]
- Budker, V., Gurevich, V., Hagstrom, J. E., Bortzov, F., Wolff, J. A. (1996). pH-sensitive, cationic liposomes: a new synthetic virus-like vector.Nat. Biotechnol. 14(6):760–764. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bulmus, V., Woodward, M., Lin, L., Murthy, N., Stayton, P., Hoffman, A. (2003). A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs.J. Control Release 93(2):105–120. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Byrnes, C. K., Nass, P. H., Duncan, M. D., Harmon, J. W. (2002). A nuclear targeting peptide, M9, improves transfection efficiency in fibroblasts.J. Surg. Res. 108(1):85–90. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Caplen, N. J. (2004). Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.Gene Ther. 11(16):1241–1248. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cevc, G., Richardsen, H. (1999). Lipid vesicles and membrane fusion.Adv. Drug Deliv. Rev. 38(3):207–232. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cha, C. W., Boden, S. D. (2003). Gene therapy applications for spine fusion.Spine. 28(15 suppl):S74–S84. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chander, R., Schreier, H. (1992). Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160.Life Sci. 50(7):481–489. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chernomordik, L. V., Leikina, E., Kozlov, M. M., Frolov, V. A., Zimmerberg, J. (1999). Structural intermediates in influenza haemagglutinin-mediated fusion.Mol. Membr. Biol. 16(1):33–42. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chin, D. J., Green, G. A., Zon, G., Szoka, F. C. Jr., Straubinger, R. M. (1990). Rapid nuclear accumulation of injected oligodeoxyribonucleotides.New Biol. 2(12):1091–1100. [PUBMED], [INFOTRIEVE]
- Chirila, T. V., Rakoczy, P. E., Garrett, K. L., Lou, X., Constable, I. J. (2002). The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.Biomaterials 23(2):321–342. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chluba, J., Lima, D. S., Frisch, B., Schuber, F. (2001). Enhancement of gene delivery by an analogue of alpha-MSH in a receptor-independent fashion.Biochim. Biophys. Acta 1510(1–2):198–208. [PUBMED], [INFOTRIEVE]
- Choi, J. S., MacKay, J. A., Szoka, F. C. Jr. (2003). Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization.Bioconjug. Chem. 14(2):420–429. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Colin, M., Maurice, M., Trugnan, G., Kornprobst, M., Harbottle, R. P., Knight, A., Cooper, R. G., Miller, A. D., Capeau, J., Coutelle, C., Brahimi-Horn, M. C. (2000). Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells.Gene Ther. 7(2):139–152. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Colin, M., Moritz, S., Fontanges, P., Kornprobst, M., Delouis, C., Keller, M., Miller, A. D., Capeau, J., Coutelle, C., Brahimi-Horn, M. C. (2001). The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties.Gene Ther. 8(21):1643–1653., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Couzin, J. (2002). Breakthrough of the year. Small RNAs make big splash.Science 298(5602):2296–2297. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Crooke, S. T. (1998). Vitravene—another piece in the mosaic.Antisense Nucleic Acid Drug Dev. 8(4):vii–viii. [PUBMED], [INFOTRIEVE], [CSA]
- Cullis, P. R., Chonn, A., Semple, S. C. (1998). Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo.Adv. Drug Deliv. Rev. 32(1–2):3–17. [PUBMED], [INFOTRIEVE]
- de Souza, D. L., Frisch, B., Duportail, G., Schuber, F. (2002). Membrane-active properties of alpha-MSH analogs: aggregation and fusion of liposomes triggered by surface-conjugated peptides.Biochim. Biophys. Acta 1558(2):222–237. [PUBMED], [INFOTRIEVE]
- Dimitriadis, G. J. (1979a). Entrapment of plasmid DNA in liposomes.Nucleic Acids Res. 6(8):2697–2705. [PUBMED], [INFOTRIEVE]
- Dimitriadis, G. J. (1979b). Cellular uptake of ribonucleic acids entrapped into liposomes.Cell Biol. Int. Rep. 3(6):543–549. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dokka, S., Rojanasakul, Y. (2000). Novel non-endocytic delivery of antisense oligonucleotides.Adv. Drug Deliv. Rev. 44(1):35–49. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Düzgünes, N., Pretzer, E., Simoes, S., Slepushkin, V., Konopka, K., Flasher, D., de Lima, M. C. (1999). Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.Mol. Membr. Biol. 16(1):111–118. [CSA], [CROSSREF]
- Edelstein, M. L., Abedi, M. R., Wixon, J., Edelstein, R. M. (2004). Gene therapy clinical trials worldwide 1989–2004—an overview.J. Gene Med. 6(6):597–602. [PUBMED], [INFOTRIEVE], [CROSSREF]
- El Aneed, A. (2004). An overview of current delivery systems in cancer gene therapy.J. Control Release 94(1):1–14. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Everts, M., Koning, G. A., Kok, R. J., Asgeirsdottir, S. A., Vestweber, D., Meijer, D. K., Storm, G., Molema, G. (2003). In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium.Pharm. Res. 20(1):64–72. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Famulok, M., Verma, S. (2002). In vivo-applied functional RNAs as tools in proteomics and genomics research.Trends Biotechnol. 20(11):462–466. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fasbender, A., Zabner, J., Chillon, M., Moninger, T. O., Puga, A. P., Davidson, B. L., Welsh, M. J. (1997). Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo.J. Biol. Chem. 272(10):6479–6489. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fattal, E., Dubernet, C., Couvreur, P. (2001). Liposome-based formulations for the delivery of oligonucleotides.STP Pharma. Sci. 11(1):34–44.
- Fattal, E., Couvreur, P., Dubernet, C. (2004). “Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.Adv. Drug Deliv. Rev. 56(7):931–946. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., Barsoum, J. (1994). Tat-mediated delivery of heterologous proteins into cells.Proc. Natl. Acad. Sci. U. S. A. 91(2):664–668. [PUBMED], [INFOTRIEVE], [CSA]
- Felgner, P. L., Ringold, G. M. (1989). Cationic liposome-mediated transfection.Nature 337(6205):387–388. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., Danielsen, M. (1987). Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.Proc. Natl. Acad. Sci. U. S. A. 84(21):7413–7417. [PUBMED], [INFOTRIEVE]
- Fraley, R., Straubinger, R. M., Rule, G., Springer, E. L., Papahadjopoulos, D. (1981). Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions.Biochemistry 20(24):6978–6987. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fretz, M. M., Koning, G. A., Mastrobattista, E., Jiskoot, W., Storm, G. (2004). OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis.Biochim. Biophys. Acta 1665(1–2):48–56. [PUBMED], [INFOTRIEVE]
- Fujii, G. (1999). To fuse or not to fuse: the effects of electrostatic interactions, hydrophobic forces, and structural amphiphilicity on protein-mediated membrane destabilization.Adv. Drug Deliv. Rev. 38(3):257–277., [PUBMED], [INFOTRIEVE], [CSA]
- Gao, X., Huang, L. (1993). Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes.Nucleic Acids Res. 21(12):2867–2872. [PUBMED], [INFOTRIEVE]
- Gao, X., Huang, L. (1996). Potentiation of cationic liposome-mediated gene delivery by polycations.Biochemistry 35(3):1027–1036. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Garcia-Chaumont, C., Seksek, O., Grzybowska, J., Borowski, E., Bolard, J. (2000). Delivery systems for antisense oligonucleotides.Pharmacol. Ther. 87(2–3):255–277. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R. E., Mason, D. Y. (1983). Transferring receptors in human tissues: their distribution and possible clinical relevance.J. Clin. Pathol. 36(5):539–545. [PUBMED], [INFOTRIEVE]
- Gerasimov, O. V., Boomer, J. A., Qualls, M. M., Thompson, D. H. (1999). Cytosolic drug delivery using pH- and light-sensitive liposomes.Adv. Drug Deliv. Rev. 38(3):317–338. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Godbey, W. T., Wu, K. K., Mikos, A. G. (1999). Poly(ethylenimine) and its role in gene delivery.J. Control Release 60(2–3):149–160. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gorlich, D., Mattaj, I. W. (1996). Nucleocytoplasmic transport.Science 271(5255):1513–1518. [PUBMED], [INFOTRIEVE]
- Guo, X., Szoka, F. C. Jr. (2001). Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG—diortho ester—lipid conjugate.Bioconjug. Chem. 12(2):291–300. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guo, W., Lee, T., Sudimack, J., Lee, R. L. (2000). Receptor-specific delivery of liposomes via folate-PEG-Chol.J. Liposome Res. 10:179–195. [CSA]
- Guo, X., MacKay, J. A., Szoka, F. C. Jr. (2003). Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid.Biophys. J. 84(3):1784–1795. [PUBMED], [INFOTRIEVE], [CSA]
- Guo, X., Huang, Z., Szoka, F. C. (2004). Improved preparation of PEG-diortho ester-diacyl glycerol conjugates.Methods Enzymol. 387:147–152. [PUBMED], [INFOTRIEVE]
- Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., de Saint, B. G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., Le Deist, F., Fischer, A., Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.Science 302(5644):415–419. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hafez, I. M., Cullis, P. R. (2001). Roles of lipid polymorphism in intracellular delivery.Adv. Drug Deliv. Rev. 47(2–3):139–148. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hafez, I. M., Ansell, S., Cullis, P. R. (2000). Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids.Biophys. J. 79(3):1438–1446. [PUBMED], [INFOTRIEVE], [CSA]
- Hafez, I. M., Maurer, N., Cullis, P. R. (2001). On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids.Gene Ther. 8(15):1188–1196. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hannon, G. J., Rossi, J. J. (2004). Unlocking the potential of the human genome with RNA interference.Nature 431(7006):371–378. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Harmsen, M. C., Swart, P. J., De Bethune, M. P., Pauwels, R., De Clercq, E., The, T. H., Meijer, D. K. (1995). Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro.J. Infect. Dis. 172(2):380–388. [PUBMED], [INFOTRIEVE]
- He, J., Furmanski, P. (1995). Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA.Nature 373(6516):721–724. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hofland, H. E., Masson, C., Iginla, S., Osetinsky, I., Reddy, J. A., Leamon, C. P., Scherman, D., Bessodes, M., Wils, P. (2002). Folate-targeted gene transfer in vivo.Mol. Ther. 5(6):739–744. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hu, Q., Bally, M. B., Madden, T. D. (2002). Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.Nucleic Acids Res. 30(16):3632–3641. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Huang, L., Li, S. (1997). Liposomal gene delivery: a complex package.Nat. Biotechnol. 15(7):620–621. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hughes, R. M. (2004). Strategies for cancer gene therapy.J. Surg. Oncol. 85(1):28–35., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hughes, M. D., Hussain, M., Nawaz, Q., Sayyed, P., Akhtar, S. (2001). The cellular delivery of antisense oligonucleotides and ribozymes.Drug Discov. Today 6(6):303–315. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ikeda, M., Sugiyama, K., Tanaka, T., Tanaka, K., Sekihara, H., Shimotohno, K., Kato, N. (1998). Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.Biochem. Biophys. Res. Commun. 245(2):549–553. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jansen, R. W., Olinga, P., Harms, G., Meijer, D. K. (1993). Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver.Pharm. Res. 10(11):1611–1614. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jarver, P., Langel, U. (2004). The use of cell-penetrating peptides as a tool for gene regulation.Drug Discov. Today 9(9):395–402. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jeong, J. H., Kim, S. W., Park, T. G. (2003). A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles.J. Control Release 93(2):183–191. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Juliano, R. L., Alahari, S., Yoo, H., Kole, R., Cho, M. (1999). Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.Pharm. Res. 16(4):494–502. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kabanov, A. V. (1999). Taking polycation gene delivery systems from in vitro to in vivo.PSST 2(9):365–372.
- Kabouridis, P. S. (2003). Biological applications of protein transduction technology.Trends Biotechnol. 21(11):498–503. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., Harashima, H. (2004). Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.Biochemistry 43(19):5618–5628. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kamps, J. A. A. M., Morselt, H. W., Swart, P. J., Meijer, D. K.F., Scherphof, G. L. (1997). Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.Proc. Natl. Acad. Sci. U. S. A. 94(21):11681–11685. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kichler, A., Frisch, B., Lima de Souza, D., Schubert, F. (2000). Receptor-mediated gene delivery with non-viral dna carriers.J. Liposome Res. 10(4):443–460. [CSA]
- Kircheis, R., Schuller, S., Brunner, S., Ogris, M., Heider, K. H., Zauner, W., Wagner, E. (1999). Polycation-based DNA complexes for tumor-targeted gene delivery in vivo.J. Gene Med. 1(2):111–120. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kisich, K. O., Malone, R. W., Feldstein, P. A., Erickson, K. L. (1999). Specific inhibition of macrophage TNF-alpha expression by in vivo ribozyme treatment.J. Immunol. 163(4):2008–2016. [PUBMED], [INFOTRIEVE]
- Knutson, V. P., Donnelly, P. V., Lopez-Reyes, M. M., Balba, Y. L.O. (1996). Receptor-mediated endocytosis. In: Andreoli, T. E., Brown, A. M., Fambrough, D. M., Hoffman, J. F., Schultz, S. G., Welsh, M. J. Molecular Biology of Membrane Transport Disorders. New York: Plenum Press, pp. 303–319.
- Koning, G. A., Storm, G. (2003). Targeted drug delivery systems for the intracellular delivery of macromolecular drugs.Drug Discov. Today 8(11):482–483. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Koning, G. A., Morselt, H. W., Gorter, A., Allen, T. M., Zalipsky, S., Kamps, J. A. A. M., Scherphof, G. L. (2001). Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.Pharm. Res. 18(9):1291–1298. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Konopka, K., Rossi, J. J., Swiderski, P., Slepushkin, V. A., Düzgünes, N. (1998a). Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes.Biochim. Biophys. Acta 1372(1):55–68. [PUBMED], [INFOTRIEVE]
- Konopka, K., Düzgünes, N., Rossi, J., Lee, N. S. (1998b). Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.J. Drug Target 5(4):247–259. [PUBMED], [INFOTRIEVE], [CSA]
- Kurreck, J. (2003). Antisense technologies. Improvement through novel chemical modifications.Eur. J. Biochem. 270(8):1628–1644. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lappalainen, K., Urtti, A., Jaaskelainen, I., Syrjanen, K., Syrjanen, S. (1994). Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.Antivir. Res. 23(2):119–130., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lavigne, C., Lunardi-Iskandar, Y., Lebleu, B., Thierry, A. R. (2004). Cationic liposomes? Lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides.Methods Enzymol. 387:189–210. [PUBMED], [INFOTRIEVE]
- Leamon, C. P., Low, P. S. (1991). Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.Proc. Natl. Acad. Sci. U. S. A. 88(13):5572–5576. [PUBMED], [INFOTRIEVE], [CSA]
- Leamon, C. P., Cooper, S. R., Hardee, G. E. (2003). Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.Bioconjug. Chem. 14(4):738–747. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lebedeva, I., Stein, C. A. (2001). Antisense oligonucleotides: promise and reality.Annu. Rev. Pharmacol. Toxicol. 41:403–419. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lechardeur, D., Sohn, K. J., Haardt, M., Joshi, P. B., Monck, M., Graham, R. W., Beatty, B., Squire, J., O'Brodovich, H., Lukacs, G. L. (1999). Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer.Gene Ther. 6(4):482–497. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lee, C. H., Ni, Y. H., Chen, C. C., Chou, C., Chang, F. H. (2003). Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells.Biochim. Biophys. Acta 1611(1–2):55–62. [PUBMED], [INFOTRIEVE]
- Lehrman, S. (1999). Virus treatment questioned after gene therapy death.Nature 401(6753):517–518. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Levay, P. F., Viljoen, M. (1995). Lactoferrin: a general review.Haematologica 80(3):252–267. [PUBMED], [INFOTRIEVE], [CSA]
- Levin, A. A. (1999). A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides.Biochim. Biophys. Acta 1489(1):69–84. [PUBMED], [INFOTRIEVE]
- Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A., Herweijer, H. (2002). Efficient delivery of siRNA for inhibition of gene expression in postnatal mice.Nat. Genet. 32(1):107–108. [PUBMED], [INFOTRIEVE]
- Li, S., Huang, L. (1997). In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes.Gene Ther. 4(9):891–900. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li, S., Rizzo, M. A., Bhattacharya, S., Huang, L. (1998). Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery.Gene Ther. 5(7):930–937. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li, W., Nicol, F., Szoka, F. C. Jr. (2004). GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery.Adv. Drug Deliv. Rev. 56(7):967–985. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Liang, E., Ajmani, P. S., Hughes, J. A. (1999). Oligonucleotide delivery: a cellular prospective.Pharmazie. 54(8):559–566. [PUBMED], [INFOTRIEVE]
- Liang, K. W., Hoffman, E. P., Huang, L. (2000). Targeted delivery of plasmid DNA to myogenic cells via transferrin-conjugated peptide nucleic acid.Mol. Ther. 1(3):236–243. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Litzinger, D. C., Brown, J. M., Wala, I., Kaufman, S. A., Van, G. Y., Farrell, C. L., Collins, D. (1996). Fate of cationic liposomes and their complex with oligonucleotide in vivo.Biochim. Biophys. Acta 1281(2):139–149. [PUBMED], [INFOTRIEVE]
- Liu, F., Huang, L. (2002). Development of non-viral vectors for systemic gene delivery.J. Control Release 78(1–3):259–266. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lonnerdal, B., Iyer, S. (1995). Lactoferrin: molecular structure and biological function.Annu. Rev. Nutr. 15:93–110. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lukacs, G. L., Haggie, P., Seksek, O., Lechardeur, D., Freedman, N., Verkman, A. S. (2000). Size-dependent DNA mobility in cytoplasm and nucleus.J. Biol. Chem. 275(3):1625–1629. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lundberg, P., Langel, U. (2003). A brief introduction to cell-penetrating peptides.J. Mol. Recognit. 16(5):227–233. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lundberg, M., Wikstrom, S., Johansson, M. (2003). Cell surface adherence and endocytosis of protein transduction domains.Mol. Ther. 8(1):143–150. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mady, M. M., Ghannam, M. M., Khalil, W. A., Repp, R., Markus, M., Rascher, W., Muller, R., Fahr, A. (2004). Efficient gene delivery with serum into human cancer cells using targeted anionic liposomes.J. Drug Target 12(1):11–18. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mandava, N., Blackburn, P., Paul, D. B., Wilson, M. W., Read, S. B., Alspaugh, E., Tritz, R., Barber, J. R., Robbins, J. M., Kruse, C. A. (2002). Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.Invest. Ophthalmol. Vis. Sci. 43(10):3338–3348. [PUBMED], [INFOTRIEVE], [CSA]
- Marcusson, E. G., Bhat, B., Manoharan, M., Bennett, C. F., Dean, N. M. (1998). Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.Nucleic Acids. Res. 26(8):2016–2023. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marshall, E. (1999). Gene therapy death prompts review of adenovirus vector.Science. 286(5448):2244–2245. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maruyama, K., Ishida, O., Takizawa, T., Moribe, K. (1999). Possibility of active targeting to tumor tissues with liposomes.Adv. Drug Deliv. Rev. 40(1–2):89–102. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Marwick, C. (1998). First “antisense” drug will treat CMV retinitis.JAMA. 280(10):871. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mastrobattista, E., Koning, G. A., van Bloois, L., Filipe, A. C., Jiskoot, W., Storm, G. (2002). Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins.J. Biol. Chem. 277(30):27135–27143. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Matteucci, M. D. (1996). Structural modifications toward improved antisense oligonucleotides.Perspect. Drug Discov. Des 4:1–16.
- Matzku, S., Krempel, H., Weckenmann, H. P., Schirrmacher, V., Sinn, H., Stricker, H. (1990). Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases.Cancer Immunol. Immunother. 31(5):285–291. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maurer, N., Mori, A., Palmer, L., Monck, M. A., Mok, K. W., Mui, B., Akhong, Q. F., Cullis, P. R. (1999). Lipid-based systems for the intracellular delivery of genetic drugs.Mol. Membr. Biol. 16(1):129–140. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McAbee, D. D., Esbensen, K. (1991). Binding and endocytosis of apo- and holo-lactoferrin by isolated rat hepatocytes.J. Biol. Chem. 266(35):23624–23631. [PUBMED], [INFOTRIEVE]
- McCaffrey, A. P., Meuse, L., Pham, T. T., Conklin, D. S., Hannon, G. J., Kay, M. A. (2002). RNA interference in adult mice.Nature 418(6893):38–39. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McManus, M. T., Sharp, P. A. (2002). Gene silencing in mammals by small interfering RNAs.Nat. Rev. Genet. 3(10):737–747. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Meijer, D. K. F., Molema, G. (1995). Targeting of drugs to the liver.Semin. Liver Dis. 15(3):202–256. [PUBMED], [INFOTRIEVE], [CSA]
- Meijer, D. K. F., Beljaars, L., Molema, G., Poelstra, K. (2001). Disease-induced drug targeting using novel peptide-ligand albumins.J. Control Release 72(1–3):157–164. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miller, K. J., Das, S. K. (1998). Antisense oligonucleotides: strategies for delivery.Pharm. Sci. Technol. Today 1(9):377–386. [CROSSREF]
- Mok, K. W., Lam, A. M., Cullis, P. R. (1999). Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties.Biochim. Biophys. Acta 1419(2):137–150. [PUBMED], [INFOTRIEVE]
- Monck, M. A., Mori, A., Lee, D., Tam, P., Wheeler, J. J., Cullis, P. R., Scherrer, P. (2000). Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection.J. Drug Target 7(6):439–452. [PUBMED], [INFOTRIEVE], [CSA]
- Mortimer, I., Tam, P., MacLachlan, I., Graham, R. W., Saravolac, E. G., Joshi, P. B. (1999). Cationic lipid-mediated transfection of cells in culture requires mitotic activity.Gene Ther. 6(3):403–411. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mukherjee, A. B., Orloff, S., Butler, J. D., Triche, T., Lalley, P., Schulman, J. D. (1978). Entrapment of metaphase chromosomes into phospholipid vesicles (lipochromosomes): carrier potential in gene transfer.Proc. Natl. Acad. Sci. U. S. A. 75(3):1361–1365. [PUBMED], [INFOTRIEVE]
- Muller, K., Nahde, T., Fahr, A., Muller, R., Brusselbach, S. (2001). Highly efficient transduction of endothelial cells by targeted artificial virus-like particles.Cancer Gene Ther. 8(2):107–117. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Murray, K. D., Etheridge, C. J., Shah, S. I., Matthews, D. A., Russell, W., Gurling, H. M., Miller, A. D. (2001). Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core.Gene Ther. 8(6):453–460. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nahde, T., Muller, K., Fahr, A., Muller, R., Brusselbach, S. (2001). Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles.J. Gene Med. 3(4):353–361. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Naslavsky, N., Weigert, R., Donaldson, J. G. (2004). Characterization of a non-clathrin endocytic pathway: membrane cargo and lipid requirements.Mol. Biol. Cell 15(8):3542–3552. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nichols, B. J., Lippincott-Schwartz, J. (2001). Endocytosis without clathrin coats.Trends Cell Biol. 11(10):406–412. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nicolau, C., Sene, C. (1982). Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage.Biochim. Biophys. Acta 721(2):185–190. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nicolau, C., Le Pape, A., Soriano, P., Fargette, F., Juhel, M. F. (1983). In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I.Proc. Natl. Acad. Sci. U. S. A. 80(4):1068–1072. [PUBMED], [INFOTRIEVE], [CSA]
- Niidome, T., Huang, L. (2002). Gene therapy progress and prospects: nonviral vectors.Gene Ther. 9(24):1647–1652. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nir, S., Nicol, F., Szoka, F. C. Jr. (1999). Surface aggregation and membrane penetration by peptides: relation to pore formation and fusion.Mol. Membr. Biol. 16(1):95–101. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nishikawa, M., Hirabayashi, H., Takakura, Y., Hashida, M. (1995). Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.Pharm. Res. 12(2):209–214. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nuijens, J. H., van Berkel, P. H., Schanbacher, F. L. (1996). Structure and biological actions of lactoferrin.J. Mammary Gland Biol. Neoplasia. 1(3):285–295. [PUBMED], [INFOTRIEVE], [CSA]
- Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., Schnitzer, J. E. (2004). Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy.Nature 429(6992):629–635. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Opalinska, J. B., Gewirtz, A. M. (2002). Nucleic-acid therapeutics: basic principles and recent applications.Nat. Rev., Drug Discov. 1(7):503–514. [CROSSREF]
- Oren, Z., Ramesh, J., Avrahami, D., Suryaprakash, N., Shai, Y., Jelinek, R. (2002). Structures and mode of membrane interaction of a short alpha helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy.Eur. J. Biochem. 269(16):3869–3880. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pagnan, G., Stuart, D. D., Pastorino, F., Raffaghello, L., Montaldo, P. G., Allen, T. M., Calabretta, B., Ponzoni, M. (2000). Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.J. Natl. Cancer Inst. 92(3):253–261. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pastorino, F., Brignole, C., Marimpietri, D., Pagnan, G., Morando, A., Ribatti, D., Semple, S. C., Gambini, C., Allen, T. M., Ponzoni, M. (2003). Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.Clin. Cancer Res. 9(12):4595–4605. [PUBMED], [INFOTRIEVE], [CSA]
- Paulos, C. M., Reddy, J. A., Leamon, C. P., Turk, M. J., Low, P. S. (2004). Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.Mol. Pharmacol. 66(6):1406–1414. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Penco, S., Scarfi, S., Giovine, M., Damonte, G., Millo, E., Villaggio, B., Passalacqua, M., Pozzolini, M., Garre, C., Benatti, U. (2001). Identification of an import signal for, and the nuclear localization of, human lactoferrin.Biotechnol. Appl. Biochem. 34(Pt 3):151–159. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pirollo, K. F., Rait, A., Sleer, L. S., Chang, E. H. (2003). Antisense therapeutics: from theory to clinical practice.Pharmacol. Ther. 99(1):55–77. [PUBMED], [INFOTRIEVE], [CSA]
- Phillips, N. C., Dahman, J. (1995). Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids.Immunol. Lett. 45(3):149–152. [PUBMED], [INFOTRIEVE], [CSA]
- Pollard, H., Toumaniantz, G., Amos, J. L., Avet-Loiseau, H., Guihard, G., Behr, J. P., Escande, D. (2001). Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids.J. Gene Med. 3(2):153–164. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ponnappa, B. C., Dey, I., Tu, G. C., Zhou, F., Aini, M., Cao, Q. N., Israel, Y. (2001). In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats.J. Pharmacol. Exp. Ther. 297(3):1129–1136. [PUBMED], [INFOTRIEVE], [CSA]
- Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G. P., Wilson, J. M., Batshaw, M. L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.Mol. Genet. Metab. 80(1–2):148–158. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rejman, J., Oberle, V., Zuhorn, I. S., Hoekstra, D. (2004). Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.Biochem. J. 377(Pt 1):159–169. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., Lebleu, B. (2003). Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.J. Biol. Chem. 278(1):585–590. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L. (1990). Gene transfer into humans–immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.N. Engl. J. Med. 323(9):570–578. [PUBMED], [INFOTRIEVE], [CSA]
- Saravolac, E. G., Ludkovski, O., Skirrow, R., Ossanlou, M., Zhang, Y. P., Giesbrecht, C., Thompson, J., Thomas, S., Stark, H., Cullis, P. R., Scherrer, P. (2000). Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.J. Drug Target 7(6):423–437. [PUBMED], [INFOTRIEVE], [CSA]
- Schatzlein, A. G. (2001). Non-viral vectors in cancer gene therapy: principles and progress.Anticancer Drugs 12(4):275–304. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scherer, L. J., Rossi, J. J. (2003). Approaches for the sequence-specific knockdown of mRNA.Nat. Biotechnol. 21(12):1457–1465. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scherphof, G. L., Koning, G., Bartsch, M., Yan, X., Kamps, J. (2002). Targeting liposomes and lipoplexes to cells in the liver.Cell Mol. Biol. Lett. 7(2):251–254. [PUBMED], [INFOTRIEVE], [CSA]
- Schiffelers, R. M., Molema, G., ten Hagen, T. L., Janssen, A. P., Schraa, A. J., Kok, R. J., Koning, G. A., Storm, G. (2002). Ligand-targeted liposomes directed against pathological vasculature.J. Liposome Res. 12(1–2):129–135. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schiffelers, R. M., Woodle, M. C., Scaria, P. (2004). Pharmaceutical prospects for RNA interference.Pharm. Res. 21(1):1–7. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schmidt-Wolf, G. D., Schmidt-Wolf, I. G. (2003). Non-viral and hybrid vectors in human gene therapy: an update.Trends Mol. Med. 9(2):67–72. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schnitzer, J. E. (2001). Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo.Adv. Drug Deliv. Rev. 49(3):265–280. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos, S. N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., Scherrer, P. (2001). Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.Biochim. Biophys. Acta 1510(1–2):152–166. [PUBMED], [INFOTRIEVE]
- Shi, N., Pardridge, W. M. (2000). Noninvasive gene targeting to the brain.Proc. Natl. Acad. Sci. U. S. A. 97(13):7567–7572. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shi, F., Hoekstra, D. (2004). Effective intracellular delivery of oligonucleotides in order to make sense of antisense.J. Control Release 97(2):189–209. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shi, N., Boado, R. J., Pardridge, W. M. (2001a). Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes.Pharm. Res. 18(8):1091–1095. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shi, F., Nomden, A., Oberle, V., Engberts, J. B., Hoekstra, D. (2001b). Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.Nucleic Acids Res. 29(10):2079–2087. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shi, F., Wasungu, L., Nomden, A., Stuart, M. C., Polushkin, E., Engberts, J. B., Hoekstra, D. (2002). Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides: role of lipid exchangeability and non-lamellar transitions.Biochem J. 366(Pt 1):333–341., [PUBMED], [INFOTRIEVE], [CSA]
- Shin, J., Shum, P., Thompson, D. H. (2003). Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids.J. Control Release 91(1–2):187–200. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simoes, S., Slepushkin, V., Pires, P., Gaspar, R., de Lima, M. P., Düzgünes, N. (1999). Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides.Gene Ther. 6(11):1798–1807. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Simoes, S., Slepushkin, V., Pires, P., Gaspar, R., Pedroso de Lima, M. C., Düzgünes, N. (2000). Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum.Biochim. Biophys. Acta 1463(2):459–469. [PUBMED], [INFOTRIEVE]
- Simoes, S., Pires, P., da Cruz, M. T., Duzgunes, N., de Lima, M. C. (2003). Gene delivery by cationic liposome-DNA complexes containing transferrin or serum albumin.Methods Enzymol. 373:369–383. [PUBMED], [INFOTRIEVE]
- Simoes, S., Moreira, J. N., Fonseca, C., Düzgünes, N., de Lima, M. C. (2004). On the formulation of pH-sensitive liposomes with long circulation times.Adv. Drug Deliv. Rev. 56(7):947–965. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sixou, S., Szoka, F. C. Jr., Green, G. A., Giusti, B., Zon, G., Chin, D. J. (1994). Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET).Nucleic Acids Res. 22(4):662–668. [PUBMED], [INFOTRIEVE]
- Smyth, T. N. (2002). Liposomal delivery of nucleic acids in vivo.DNA Cell Biol. 21(12):857–867. [CSA], [CROSSREF]
- Song, L. Y., Ahkong, Q. F., Rong, Q., Wang, Z., Ansell, S., Hope, M. J., Mui, B. (2002). Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes.Biochim. Biophys. Acta 1558(1):1–13. [PUBMED], [INFOTRIEVE]
- Song, E., Lee, S. K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., Lieberman, J. (2003). RNA interference targeting Fas protects mice from fulminant hepatitis.Nat. Med. 9(3):347–351. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sorensen, D. R., Leirdal, M., Sioud, M. (2003). Gene silencing by systemic delivery of synthetic siRNAs in adult mice.J. Mol. Biol. 327(4):761–766. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stahel, R. A., Zangemeister-Wittke, U. (2003). Antisense oligonucleotides for cancer therapy—an overview.Lung Cancer 41 suppl 1:S81–S88. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- St. George, J. A. (2003). Gene therapy progress and prospects: adenoviral vectors.Gene Ther. 10(14):1135–1141. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stuart, D. D., Allen, T. M. (2000). A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability.Biochim. Biophys. Acta 1463(2):219–229. [PUBMED], [INFOTRIEVE]
- Stuart, D. D., Kao, G. Y., Allen, T. M. (2000). A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.Cancer Gene Ther. 7(3):466–475. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stuart, D. D., Semple, S. C., Allen, T. M. (2004). High efficiency entrapment of antisense oligonucleotides in liposomes.Methods Enzymol. 387:171–188. [PUBMED], [INFOTRIEVE]
- Subramanian, A., Ranganathan, P., Diamond, S. L. (1999). Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells.Nat. Biotechnol. 17(9):873–877. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sugiyama, M., Matsuura, M., Takeuchi, Y., Kosaka, J., Nango, M., Oku, N. (2004). Possible mechanism of polycation liposome (PCL)-mediated gene transfer.Biochim. Biophys. Acta 1660(1–2):24–30. [PUBMED], [INFOTRIEVE]
- Szoka, F. Jr., Papahadjopoulos, D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.Proc. Natl. Acad. Sci. U. S. A. 75(9):4194–4198. [PUBMED], [INFOTRIEVE]
- Tan, P. H., King, W. J., Chen, D., Awad, H. M., Mackett, M., Lechler, R. I., Larkin, D. F., George, A. J. (2001). Transferrin receptor-mediated gene transfer to the corneal endothelium.Transplantation 71(4):552–560. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tan, P. H., Manunta, M., Ardjomand, N., Xue, S. A., Larkin, D. F., Haskard, D. O., Taylor, K. M., George, A. J. (2003). Antibody targeted gene transfer to endothelium.J. Gene Med. 5(4):311–323. [CROSSREF]
- Torchilin, V. P., Rammohan, R., Weissig, V., Levchenko, T. S. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.Proc. Natl. Acad. Sci. U. S. A. 98(15):8786–8791. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., D'Souza, G. G. (2003). Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.Proc. Natl. Acad. Sci. U. S. A. 100(4):1972–1977. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Uil, T. G., Haisma, H. J., Rots, M. G. (2003). Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.Nucleic Acids Res. 31(21):6064–6078. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ulvatne, H., Haukland, H. H., Olsvik, O., Vorland, L. H. (2001). Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes.FEBS Lett. 492(1–2):62–65. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Uyechi, L. S., Gagne, L., Thurston, G., Szoka, F. C. Jr. (2001). Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components.Gene Ther. 8(11):828–836. [PUBMED], [INFOTRIEVE], [CROSSREF]
- van der Sluijs, P., Bootsma, H. P., Postema, B., Moolenaar, F., Meijer, D. K. (1986). Drug targeting to the liver with lactosylated albumins: does the glycoprotein target the drug or is the drug targeting the glycoprotein. Hepatology. 6(4):723–728.
- van Rossenberg, S. M., Sliedregt-Bol, K. M., Meeuwenoord, N. J., Van Berkel, T. J., van Boom, J. H., van der Marel, G. A., Biessen, E. A. (2002). Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery.J. Biol. Chem. 277(48):45803–45810. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vives, E., Brodin, P., Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.J. Biol. Chem. 272(25):16010–16017. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vogel, H. J., Schibli, D. J., Jing, W., Lohmeier-Vogel, E. M., Epand, R. F., Epand, R. M. (2002). Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides.Biochem. Cell Biol. 80(1):49–63. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wagner, E., Kircheis, R., Walker, G. F. (2004). Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.Biomed. Pharmacother. 58(3):152–161. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., Low, P. S. (1995). Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.Proc. Natl. Acad. Sci. U. S. A. 92(8):3318–3322. [PUBMED], [INFOTRIEVE], [CSA]
- Welz, C., Neuhuber, W., Schreier, H., Repp, R., Rascher, W., Fahr, A. (2000a). Nuclear gene targeting using negatively charged liposomes.Int. J. Pharm. 196(2):251–252. [PUBMED], [INFOTRIEVE]
- Welz, C., Neuhuber, W., Schreier, H., Metzler, M., Repp, R., Rascher, W., Fahr, A. (2000b). Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes.Pharm. Res. 17(10):1206–1211. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wilson, T., Papahadjopoulos, D., Taber, R. (1979). The introduction of poliovirus RNA into cells via lipid vesicles (liposomes).Cell. 17(1):77–84. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P., Cullis, P. R. (1999). Stabilized plasmid-lipid particles: construction and characterization.Gene Ther. 6(2):271–281. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wreschner, D. H., Gregoriadis, G., Gunner, D. B., Dourmashkin, R. R. (1978). Entrapment of mRNA and rRNA into large monolamellar liposomes derived from hybrid small monolamellar liposomes.Biochem. Soc. Trans. 6(5):930–933. [PUBMED], [INFOTRIEVE]
- Xu, L., Pirollo, K. F., Tang, W. H., Rait, A., Chang, E. H. (1999). Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.Hum. Gene Ther. 10(18):2941–2952. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Xu, L., Tang, W. H., Huang, C. C., Alexander, W., Xiang, L. M., Pirollo, K. F., Rait, A., Chang, E. H. (2001). Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.Mol. Med. 7(10):723–734.
- Xu, L., Huang, C. C., Huang, W., Tang, W. H., Rait, A., Yin, Y. Z., Cruz, I., Xiang, L. M., Pirollo, K. F., Chang, E. H. (2002a). Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.Mol. Cancer Ther. 1(5):337–346. [PUBMED], [INFOTRIEVE], [CSA]
- Xu, L., Frederik, P., Pirollo, K. F., Tang, W. H., Rait, A., Xiang, L. M., Huang, W., Cruz, I., Yin, Y., Chang, E. H. (2002b). Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery.Hum. Gene Ther. 13(3):469–481. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yang, L., Li, J., Zhou, W., Yuan, X., Li, S. (2004). Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells.J. Control Release 95(2):321–331. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yu, W., Pirollo, K. F., Rait, A., Yu, B., Xiang, L. M., Huang, W. Q., Zhou, Q., Ertem, G., Chang, E. H. (2004). A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.Gene Ther. 11(19):1410–1434. [CROSSREF]
- Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A., Welsh, M. J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid.J. Biol. Chem. 270(32):18997–19007. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zamecnik, P. C., Stephenson, M. L. (1978). Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.Proc. Natl. Acad. Sci. U. S. A. 75(1):280–284. [PUBMED], [INFOTRIEVE]
- Zelphati, O., Szoka, F. C. Jr. (1996). Mechanism of oligonucleotide release from cationic liposomes.Proc. Natl. Acad. Sci. U. S. A. 93(21):11493–11498. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zeng, Y., Tao, N., Chung, K. N., Heuser, J. E., Lublin, D. M. (2003). Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1.J. Biol. Chem. 278(46):45931–45936. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zhang, Y. P., Sekirov, L., Saravolac, E. G., Wheeler, J. J., Tardi, P., Clow, K., Leng, E., Sun, R., Cullis, P. R., Scherrer, P. (1999). Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties.Gene Ther. 6(8):1438–1447. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zhang, Y., Schlachetzki, F., Pardridge, W. M. (2003). Global non-viral gene transfer to the primate brain following intravenous administration.Mol. Ther. 7(1):11–18. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang, C. Y., Taylor, M. M., Samson, W. K., Phillips, M. I. (2004). Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.Methods Mol. Med. 106:11–34. [CSA]
- Zhao, X. B., Lee, R. J. (2004). Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor.Adv. Drug Deliv. Rev. 56(8):1193–1204. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhou, W., Yuan, X., Wilson, A., Yang, L., Mokotoff, M., Pitt, B., Li, S. (2002). Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles.Bioconjug. Chem. 13(6):1220–1225. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ziere, G. J., van Dijk, M. C., Bijsterbosch, M. K., Van Berkel, T. J. (1992). Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues.J. Biol. Chem. 267(16):11229–11235. [PUBMED], [INFOTRIEVE]
- Zuhorn, I. S., Kalicharan, R., Hoekstra, D. (2002). Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis.J. Biol. Chem. 277(20):18021–18028. [PUBMED], [INFOTRIEVE], [CROSSREF]